Cytoki Pharma secures $45M Series A round lead by Lundbeckfonden Emerge together with Ysios, Seventure Partners and +ND Capital
05/05/2021 Press release CYTOKI PHARMA RAISES $45 MILLION SERIES A FINANCING. Proceeds to support the development of its lead program (lipidated IL-22) through clinical proof of concept in Inflammatory Bowel Disease and explore expansion in additional pathologies related to epithelial tissue injury Copenhagen, Denmark – 04 May 2021 –…